Sahajanand Medical Files for Rs.1,500 Crore IPO

Sahajanand Medical files for Rs.1,500 crore IPO

by 5paisa Research Team Last Updated: Dec 15, 2022 - 12:17 am 51.3k Views
Listen icon

Sahajanand Medical Technologies has filed the draft red herring prospectus (DRHP) with SEBI for its proposed Rs.1,500 crore IPO. The company is into the design and manufacture of vascular devices, with specialization in stents. Sahajanand already has strong institutional PE backing with investments from Samara Capital and Morgan Stanley PE Fund.

The Rs.1,500 crore IPO will comprise of a fresh issue of Rs.410 crore and an offer for sale of Rs.1,090 crore. While the OFS will be used to give partial exit to the promoters and to the early investors, the fresh issue component will be predominantly used by the company to reduce its debt and deleverage its balance sheet and also for working capital purposes.

Currently, the company is predominantly PE Fund owned. While Morgan Stanley PE Fund has a 18.44% stake, Samara Capital has a 36.59% stake in Sahajanand Medical Technologies. The company is based out of Surat in Gujarat and is a leader in drug eluting stents (DES). In the year FY21, it had a 31% share of the DES market, making it the undisputed niche leader.

Cardio vascular diseases are striking people more frequently and also striking them  early. Hence it is critical that people are able to lead a normal life despite cardio vascular problems. The vascular devices market is expected to grow at 8.6% between 2021 and 2026 even as the incidence of cardio vascular afflictions have doubled globally in last 30 years.

The COVID pandemic has resulted in greater health consciousness and the vascular devices market is also likely to benefit from this trend. The global market size of cardio vascular devices is close to $26 billion and this is likely to see steady growth in the coming years. That will also open up a huge global opportunity for the stent manufacturer.

The Sahajanand Medical IPO will be managed by Axis Bank, BOFA Securities, Edelweiss and UBS. This marks the second IPO filing by a medical devices manufacturer. The first such company to file DRHP was Healthium Medtech, which is largely into surgical sutures and medical consumables.

Also Read:-

List of Upcoming IPOs in 2021

How do you rate this blog?

Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage


About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Open Free Demat Account
Resend OTP
Please Enter OTP
Mobile No. belongs to

By proceeding, you agree to the T&C.

Latest Blogs
Weekly Market Outlook for 4th March to 8th March

In the week gone by, Nifty traded with higher volatility as the index corrected during mid-week upto 21860, but it then witnessed a smart recovery to register new record high and the index ended the week just below 22400 with weekly gains of three-fourth of a percent.

Best EV Stocks in India 2024

As India shifts to a greener future, the electrically powered cars and trucks market will rise significantly in 2024. This article investigates the best EV stocks in India, highlighting firms leading the way in innovation, sustainability, and market capitalization.

Best Banks in India 2024

Navigating the many options for banking services becomes a crucial task for both individuals and enterprises as we enter the Indian financial scene in 2024. The top banks in India provide a wide range of services that extend beyond traditional banking, serving as cornerstones of the country's financial stability. These best banks in India offer individualized client care and state-of-the-art digital solutions that reflect the changing needs of the financial industry.